Cytoki Pharma: Clinical Trials

2 trials sponsored by Cytoki Pharma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Terminated 1

Follow Cytoki Pharma: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
CK-0045 Proof-of-concept Study in Participants With Overweight / Obesity and Type 2 Diabetes
CK-0045, Placebo - Type 2 Diabetes Mellitus (T2DM), Obesity and Overweight
Phase 2TerminatedCytoki Pharma902024-09-062026-02-20
A Phase 1 Study to Investigate Safety, Tolerability, and Pharmacokinetics of CK-0045 in Healthy Participants and Otherwise Healthy Participants With Obesity
CK-0045, Placebo - Healthy
Phase 1CompletedCytoki Pharma762022-12-262024-01-10

Conditions studied

Diabetes Mellitus, Type 2 (1)  ·  Obesity (1)  ·  Overweight (1)

Countries

Belgium (1)  ·  Germany (1)

Top investigators

Lotte Verwillingen, MD (1)  ·  Tim Heise, MD (1)